Trending...
- Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1
- Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon
- Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX
BELLEVUE, Wash. - Washingtoner -- mpathic, a leading provider of AI-powered emotional intelligence solutions, is proud to announce that it has successfully completed SOC 2 Type II audit. This audit further solidifies the company's dedication to data security and compliance.
SOC 2 Type II compliance is a rigorous and internationally recognized standard that validates a company's commitment to safeguarding sensitive information and ensuring the highest level of data security and privacy for its clients.
By undergoing a thorough and independent audit from a leading audit body, mpathic has demonstrated its robust internal controls and processes for data protection, availability, and confidentiality. This certification provides valuable assurance to mpathic's clients that their data is handled with the utmost care and security.
Key highlights of mpathic's completion of the SOC 2 Type II audit include:
More on Washingtoner
Brian Williams, Chief Technology & Information Security Officer of mpathic, commented on this significant achievement, saying, "We understand the critical importance of data security and compliance in our industry. The completion of the SOC 2 Type II audit underscores our unwavering commitment to maintaining the highest standards of data protection and security for our clients. We believe that our clients' trust is the foundation of our success, and this compliance is a testament to that trust."
mpathic's successful completion of the SOC 2 Type II audit exemplifies the company's ongoing efforts to deliver cutting-edge solutions while prioritizing data security, privacy, and regulatory compliance.
For more information about mpathic and its SOC 2 Type II audit, please visit mpathic.ai.
Follow our blog (https://www.mpathic.ai/blog) and connect with us on LinkedIn (https://www.linkedin.com/company/mpathic-ai/).
More on Washingtoner
About mpathic
mpathic (https://www.mpathic.ai/) is a trusted leader in actionable conversation analytics, empowering healthcare, pharma, sales, and service leaders to deliver exceptional care and engagement. With our proprietary ML models, developed through over 10 years of scientific validation, mpathic achieves up to 7 times the accuracy of human doctors. Our platform objectively detects, corrects, and enhances over 90 behaviors, establishing an unrivaled level of trust.
SOC 2 Type II compliance is a rigorous and internationally recognized standard that validates a company's commitment to safeguarding sensitive information and ensuring the highest level of data security and privacy for its clients.
By undergoing a thorough and independent audit from a leading audit body, mpathic has demonstrated its robust internal controls and processes for data protection, availability, and confidentiality. This certification provides valuable assurance to mpathic's clients that their data is handled with the utmost care and security.
Key highlights of mpathic's completion of the SOC 2 Type II audit include:
- Stringent Security Measures: mpathic has implemented stringent security measures to protect client data from unauthorized access, ensuring data integrity and confidentiality throughout its systems.
- Continuous Monitoring: mpathic's commitment to data security extends to continuous monitoring and auditing of its internal controls, guaranteeing the effectiveness of security measures over time.
- Comprehensive Compliance: mpathic adheres to the highest industry standards, including HIPAA and GDPR, to ensure compliance with data protection regulations specific to healthcare and clinical research.
More on Washingtoner
- Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event
- KeysCaribbean Announces Temporarily Reduced Rates At Village at Hawks Cay Villas
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
- Electives Launches "Electives for Everyone," Making Live Expert-Led Learning Available to Every Employee
- Tax Tops the List as Wealthy Brits Plan Their Exit, La Vida Survey Finds
Brian Williams, Chief Technology & Information Security Officer of mpathic, commented on this significant achievement, saying, "We understand the critical importance of data security and compliance in our industry. The completion of the SOC 2 Type II audit underscores our unwavering commitment to maintaining the highest standards of data protection and security for our clients. We believe that our clients' trust is the foundation of our success, and this compliance is a testament to that trust."
mpathic's successful completion of the SOC 2 Type II audit exemplifies the company's ongoing efforts to deliver cutting-edge solutions while prioritizing data security, privacy, and regulatory compliance.
For more information about mpathic and its SOC 2 Type II audit, please visit mpathic.ai.
Follow our blog (https://www.mpathic.ai/blog) and connect with us on LinkedIn (https://www.linkedin.com/company/mpathic-ai/).
More on Washingtoner
- FloorLine Launches Live Shop Floor Tracking for Small Manufacturers
- "The Tree of Cinema" Installation Brought Film History and Its Audiences Together at TIFF 2026
- Detroit Lawyer Steals $600,000 Settlement Meant to Protect Child
- The TOPS Trap: Local AI Models Hallucinated Facts, Cited Real Sources, and Sounded Confident
- Final Week to Register for Free Spokane Community Conference
About mpathic
mpathic (https://www.mpathic.ai/) is a trusted leader in actionable conversation analytics, empowering healthcare, pharma, sales, and service leaders to deliver exceptional care and engagement. With our proprietary ML models, developed through over 10 years of scientific validation, mpathic achieves up to 7 times the accuracy of human doctors. Our platform objectively detects, corrects, and enhances over 90 behaviors, establishing an unrivaled level of trust.
Source: mpathic
Filed Under: Technology
0 Comments
Latest on Washingtoner
- ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
- Revinate launches hospitality's first data activation platform
- HLN Consulting Names Lilly Kan as Its First Chief Executive Officer
- BitTitan Accelerates Large-Scale Document Migrations with MigrationWiz
- Clearnetworx Deploys netElastic vBNG, CGNAT And netVision To Power Fiber Expansion Across Colorado's Western Slope
- Spokane: SPD Seeks Assistance in Locating Vehicle Associated in Hit and Run
- Tacoma: 'Capital Ready: Preparing Businesses for Growth in Public Contracting' Workshop on October 27
- Six Tacoma Census Tracts Nominated by Governor Bob Ferguson as Federal 'Opportunity Zones'
- Seven Spokane Census Tracts Receive Opportunity Zone Designations
- Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources
- Hilton Waikiki Beach Resort & Spa Introduces Level 37 Sky Lounge by Casamigos
- Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon
- Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX
- Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1
- Vegan Kingz Expands Direct-Import Wholesale Lineup to Help Commercial Kitchens Cut Ingredient Costs
- Acuvance Survey Finds ERP Integration Remains a Key Challenge as Healthcare Organizations Prepare for AI
- Everything Policy Unveils Their Classroom Resources Behind Every Policy Topic
- Constantine "Costa" Kapothanasis II Acquires The Lubri-Loy Company, Carrying a 77-Year-Old American Lubricant Brand Into Its Next Era
- LS2 Partners with Angels Of Dirt's "Next Chapter Racer" Series Celebrating Women and Girls in Motorsports
- Danish company biosuite introduces biotech procurement software to track outsourced R&D commitments